Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Sale of 1,367 GPCR shares, $68.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Structure Therapeutics Inc. (GPCR) | Sale | 1,367 | $68.4K |
| Jun 29, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 33,372 | $1.17M |
| May 5, 2026 | Avalyn Pharma Inc. (AVLN) | Conversion | 727,585 | n/a |
| Apr 16, 2026 | Structure Therapeutics Inc. (GPCR) | Sale | 1,367 | $75.3K |
| Jan 20, 2026 | Structure Therapeutics Inc. (GPCR) | Sale | 465 | $38.2K |
| Dec 10, 2025 | Structure Therapeutics Inc. (GPCR) | Sale | 709 | $65.6K |
| Oct 29, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 459 | $12.2K |
| Oct 8, 2025 | Beam Therapeutics Inc. (BEAM) | Gift | 1,232,434 | n/a |
| Aug 1, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 48,374 | $991.7K |
| Aug 1, 2025 | Structure Therapeutics Inc. (GPCR) | Sale | 26,310 | $470.2K |